Salazar-Vizcaya et al., Potential of short-term intensive intervention to interrupt HCV transmission in MSM
On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: a mathematical modelling study. Journal of Viral Hepatitis Salazar-Vizcaya et al. assessed the potential to interrupt hepatitis C virus (HCV) transmission among HCV-positive men who have sex with men (MSM) of the Swiss-HCVree-trial and […]
Borges et al., Le début d’un traitement précoce diminue le risque de maladies cancéreuse
Le début d’un traitement antirétroviral immédiat dans la phase précoce de l’infection VIH diminue le risque d’être atteint d’une maladie cancéreuse. Clinical Infectious Diseases Le risque d’être atteint d’une maladie cancéreuse est plus élevé chez les personnes atteintes du VIH. L’apparition de certaines maladies cancéreuses est clairement favorisée par la présence simultanée d’une infection VIH. […]
Borges et al., L’inizio immediato di una terapia diminuisce il rischio di sviluppare un tumore maligno
L’inizio immediato di una terapia antiretrovirale nella fase precoce dell’infezione HIV diminuisce il rischio di sviluppare un tumore maligno. Clinical Infectious Diseases Il rischio di essere colpiti da una malattia neoplastica è più elevato nelle persone con infezione HIV. L’apparizione di certi tumori maligni è chiaramente favorita dalla presenza simultanea dell’HIV e in […]
Borges et al., Früher Therapiebeginn reduziert Krebsrisiko
Der unmittelbare Beginn einer antiretroviralen Therapie in der Frühphase der HIV-Infektion reduziert das Risiko für Krebserkrankungen. Clinical Infectious Diseases HIV-infizierte Personen haben im Vergleich zur Allgemeinbevölkerung ein höheres Risiko an Krebs zu erkranken. Die Entstehung einiger Krebsarten wird durch das gleichzeitige Vorliegen von HIV klar begünstigt, man nennt diese Krebsarten deshalb auch HIV-bezogene Krebse. Dazu […]
Cozzi-Lepri et al., Raltegravir and the risk of malignancies and mortality
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based cART regimens. HIV Medicine Cozzi-Lepri et al. on behalf of the EuroSIDA Study Group aimed to compare the incidences of malignancies and other comorbidities as well as survival rates in cohorts of individuals initiating raltegravir (RAL-) based and non-RAL-based […]
Peters et al., Mortality in hepatitis C virus–treated HIV patients
Is response to anti-hepatitis C virus treatment predictive of mortality in hepatitis C virus/HIV-positive patients? AIDS Peters et al. The Hepatitis C Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord aimed to compare the long-term risk of all-cause mortality and liver-related death according to response to pegylated interferon […]
Kamal et al., HIV-infected patients’ beliefs about co-treatments compared with cART
HIV-infected patients’ beliefs about their chronic co-treatments in comparison with their combined antiretroviral therapy. HIV Medicine Kamal et al. tested the hypothesis that patients’ perceptions of and attitudes towards their combination antiretroviral therapy (cART), which is perceived as crucial to their survival, differ from their beliefs about their co-treatments, and this may have an […]
Bohlius et al., Regional Kaposi sarcoma risk in HIV-positive adults
Comparison of Kaposi sarcoma risk in HIV-positive adults across five continents: a multiregional multicohort study. Clinical Infectious Diseases Bohlius et al. on behalf of the AIDS-defining Cancer Project Working Group in EuroCoord aimed to compare Kaposi sarcoma (KS) incidence rates in HIV-positive adults who started antiretroviral therapy (ART) across different continents, and to […]
Schäfer et al., Activité physique réduite chez les patients de la SHCS
Activité physique réduite chez les patients de l’Etude suisse de cohorte VIH. AIDS Care Faire du sport est bon pour la santé, dit un dicton. En effet, il a pu être démontré que chez les personnes séronégatives une activité physique régulière diminue la mortalité et ceci en particulier grâce à une réduction de risque […]
Schäfer et al., Scarsa attività fisica nei partecipanti allo studio svizzero della coorte HIV
Scarsa attività fisica nei partecipanti allo studio svizzero della coorte HIV. AIDS Care Fare sport fa bene alla salute è un detto noto a tutti. Presso le persone sieronegative è stato dimostrato che un’attività fisica regolare diminuisce la mortalità e ciò soprattutto grazie alla riduzione del rischio di malattie cardiovascolari. Ricercatori dello Studio svizzero della […]